KD Logo

A company insider recently sold 10,000 shares of MaxCyte Inc [MXCT]. Should You Sale?

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. MaxCyte Inc shares valued at $39,900 were sold by Johnston John Joseph on Jun 27 ’24. At $3.99 per share, Johnston John Joseph sold 10,000 shares. The insider’s holdings dropped to 141,950 shares worth approximately $0.53 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Ross Thomas M. sold 33,333 shares, netting a total of over 136,465 in proceeds. Following the sale of shares at $4.09 each, the insider now holds 25,000 shares.

Before that, Masoud Maher had added 70,443 shares to its account. In a trade valued at $345,241, the President and CEO bought MaxCyte Inc shares for $4.90 each. Upon closing the transaction, the insider’s holdings increased to 70,443 shares, worth approximately $0.38 million.

As published in their initiating research note from Craig Hallum on November 29, 2023, MaxCyte Inc [MXCT] has been a Buy and the price target has been revised to $7. As of August 24, 2021, William Blair has initiated its “an Outperform” rating for MXCT. Earlier on August 24, 2021, Wedbush initiated its rating. Their recommendation was “an Outperform” for MXCT stock.

Analyzing MXCT Stock Performance

During the last five days, there has been a drop of approximately -5.53%. Over the course of the year, MaxCyte Inc shares have dropped approximately -20.00%. Shares of the company reached a 52-week high of $5.55 on 01/12/24 and a 52-week low of $3.57 on 04/30/24. A 50-day SMA is recorded $4.35, while a 200-day SMA reached $4.23. Nevertheless, trading volume fell to 0.36 million shares from 0.41 million shares the previous day.

Support And Resistance Levels for MaxCyte Inc (MXCT)

According to the 24-hour chart, there is a support level at 3.68, which, if violated, would cause prices to drop to 3.59. In the upper region, resistance lies at 3.82. The next price resistance is at 3.87. RSI (Relative Strength Index) is 32.34 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.43, which suggests the price will decrease in the coming days. Percent R is at 92.20%, indicating bearish price movement. Stochastics%K at buying indicates that the stock is to be held.

Most Popular